GTG 5.06% 7.5¢ genetic technologies limited

once they sign a distribution deal would expect a massive...

  1. 20,449 Posts.
    lightbulb Created with Sketch. 268

    once they sign a distribution deal would expect a massive rerate, from lastest announcement expected in coming months:

    Commercialisation and Product Distribution Plans:

    GTG intends to introduce the new ‘GeneType for Colorectal Cancer’ and ‘GeneType for Breast Cancer’genetic tests to healthcare providers through a global network of distribution partners. The Company hasalready announced it is working with TGen in the United States and also Chinese partners connected to theHainan Free-Trade Zone. More announcements are anticipated in this regard in coming months as GTG movesto commercialise its suite of world-leading genetic tests.
 
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
-0.004(5.06%)
Mkt cap ! $9.916M
Open High Low Value Volume
7.6¢ 8.1¢ 7.3¢ $18.25K 233.9K

Buyers (Bids)

No. Vol. Price($)
1 232 7.8¢
 

Sellers (Offers)

Price($) Vol. No.
7.9¢ 8905 1
View Market Depth
Last trade - 15.37pm 28/06/2024 (20 minute delay) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.